Condition
Refractory Solid Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Refractory Solid Tumors clinical trials that are recruiting, at sites in 2 countries (most in China (3), United States (3)). By phase: Early Phase 1 (3), Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest Refractory Solid Tumors clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using PEEL-224 with Vincristine and Temozolomide for Pediatric Solid Tumors | Phase 1/2 | Los Angeles, California and 6 other locations | Recruiting | Dec 6, 2024 |
| Personalized cell therapy for advanced solid tumors | Early Phase 1 | Beijing | Recruiting | Nov 29, 2023 |
| Combining Eribulin, Irinotecan, and Temozolomide for Children with Tough Solid Tumors | Phase 1 | Houston, Texas | Recruiting | Aug 23, 2023 |
| Injection of TCR-T cells for treating solid tumors | Early Phase 1 | Nanning, Guangxi | Recruiting | Apr 13, 2023 |
| Treatment using TCR-T cells for patients with advanced solid tumors | Early Phase 1 | Nanning, Guangxi | Recruiting | Sep 14, 2022 |
| Understanding rare solid tumors and their genetic factors | — | Bethesda, Maryland and 2 other locations | Recruiting | Nov 14, 2018 |
All recruiting trials (6)
-
Using PEEL-224 with Vincristine and Temozolomide for Pediatric Solid Tumors
This study is testing a new treatment called PEEL-224, alone and with other drugs, to see if it can help children with tough-to-treat solid tumors like neuroblastoma and rhabdomyosarcoma.
-
Personalized cell therapy for advanced solid tumors
This study is testing a personalized cell therapy to see if it can help people with tough-to-treat advanced solid tumors feel better.
-
Combining Eribulin, Irinotecan, and Temozolomide for Children with Tough Solid Tumors
This study is testing a combination of three cancer drugs to see how well they work and how safe they are for children with tough solid tumors that haven't responded to other treatments.
-
Injection of TCR-T cells for treating solid tumors
This study tests if a new injection of TCR-T cells can help people with hard-to-treat solid tumors feel better and live longer.
-
Treatment using TCR-T cells for patients with advanced solid tumors
This study is testing a new treatment using TCR-T cell therapy to see if it can help patients with advanced solid tumors that haven't responded to other treatments.
-
Understanding rare solid tumors and their genetic factors
This study is looking to learn more about rare solid tumors and their genetic factors by collecting samples and medical histories from people who have these tumors to help improve future treatments and prevention.
Related topics
Quick answers
How many Refractory Solid Tumors clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), United States (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 3, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.